Cargando…
HIV-1 Latency and Latency Reversal: Does Subtype Matter?
Cells that are latently infected with HIV-1 preclude an HIV-1 cure, as antiretroviral therapy does not target this latent population. HIV-1 is highly genetically diverse, with over 10 subtypes and numerous recombinant forms circulating worldwide. In spite of this vast diversity, much of our understa...
Autores principales: | Sarabia, Indra, Bosque, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950696/ https://www.ncbi.nlm.nih.gov/pubmed/31795223 http://dx.doi.org/10.3390/v11121104 |
Ejemplares similares
-
Structure-Activity Relationship Analysis of Benzotriazine Analogues as HIV-1 Latency-Reversing Agents
por: Sorensen, Eric S., et al.
Publicado: (2020) -
The Intact Noninducible Latent HIV-1 Reservoir Is Established in an In Vitro Primary T(CM) Cell Model of Latency
por: Sarabia, Indra, et al.
Publicado: (2021) -
New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
por: Lewis, Catherine A., et al.
Publicado: (2023) -
Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation
por: Kauder, Steven E., et al.
Publicado: (2009) -
The role of latency reversal in HIV cure strategies
por: Tanaka, Kiho, et al.
Publicado: (2022)